Valuation: ApicHope Pharmaceutical Group Co., Ltd.

Market Cap 16.97B 2.52B 2.17B 2.04B 1.86B 3.49B 241B 3.54B 23.9B 9.36B 121B 9.45B 9.25B 401B P/E 2026 *
32.6x
P/E 2027 * -164x
Enterprise Value 16.97B 2.52B 2.17B 2.04B 1.86B 3.49B 241B 3.54B 23.9B 9.36B 121B 9.45B 9.25B 401B EV / Sales 2026 *
15.7x
EV / Sales 2027 * 13.5x
Free-Float
31.84%
Yield 2026 *
-
Yield 2027 * -
1 day-2.30%
1 week-0.42%
Current month+7.17%
1 month-9.61%
3 months-5.64%
6 months+13.64%
Current year+12.76%
1 week 36.46
Extreme 36.46
39.95
1 month 33.41
Extreme 33.41
39.95
Current year 29.31
Extreme 29.31
45.88
1 year 29.31
Extreme 29.31
76.88
3 years 12.74
Extreme 12.74
81.48
5 years 12.74
Extreme 12.74
81.48
10 years 7.58
Extreme 7.577775
81.48
Manager TitleAgeSince
Chief Executive Officer 52 11/11/2015
Director of Finance/CFO 60 11/11/2015
Investor Relations Contact 38 31/12/2020
Director TitleAgeSince
Chairman 52 11/11/2015
Director/Board Member 58 11/11/2015
Chairman 50 11/11/2015
Date Insider Type Main position Quantity % Market Cap.
1/5/26 A Buy

Director

4,200 0.0010%
11/24/25 A Buy

Director

7,000 0.0017%
9/1/23 A Buy 20,000 0.0089%
Change 5-day change 1-year change 3-year change Capi.($)
-2.30%-0.42%-46.42%+87.84% 2.57B
-2.49%-3.24%+14.66%+64.56% 48.43B
-0.12%-5.43%+52.28%+115.90% 39.72B
-1.28%-2.21%-8.47%+15.11% 12.25B
-0.33%+1.55%+14.43%+72.12% 11.84B
-0.58%-0.77%+29.90%+141.59% 9.06B
0.00%+1.64%+22.99%+39.94% 7.57B
-0.88%+1.18%+40.97%-13.86% 7.18B
+0.46%+2.19%+13.91%+192.06% 6.84B
+0.63%-2.53%-30.10%+23.84% 5.77B
Average -0.69%+0.43%+10.42%+73.91% 15.12B
Weighted average by Cap. -1.03%-1.17%+22.45%+78.91%

Financials

2026 *2027 *
Net sales 1.08B 160M 138M 130M 118M 222M 15.32B 225M 1.52B 596M 7.67B 601M 588M 25.53B 1.26B 187M 161M 151M 138M 259M 17.84B 262M 1.77B 694M 8.94B 701M 685M 29.74B
Net income 526M 78.03M 67.36M 63.2M 57.56M 108M 7.46B 110M 741M 290M 3.74B 293M 287M 12.43B -102M -15.13M -13.06M -12.25M -11.16M -20.99M -1.45B -21.28M -144M -56.3M -725M -56.81M -55.58M -2.41B
Net Debt - -
Logo ApicHope Pharmaceutical Group Co., Ltd.
ApicHope Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the research and development, production and sales of pharmaceuticals. The Company mainly focuses on the fields of pediatrics drug and chronic disease drug, and its product categories cover chemical medicine (including raw materials and preparations), special Chinese patent medicine, biological vaccines and other fields. The Company’s paediatric drugs are used to treat common diseases, such as children's influenza, colds, infectious diseases, functional dyspepsia and others. The Company’s chronic disease drugs are used for treatment of cardiovascular and cerebrovascular diseases, kidney diseases, digestive system diseases, liver diseases and other diseases. The Company’s main products include Fuganlin oral liquid, clindamycin hydrochloride palmitate dispersible tablets and other products. The Company mainly conducts its business in the domestic market.
Employees
1,294
Date Price Change Volume
17/08/26 CN¥37.83 -2.30% 12,659,820
14/08/26 CN¥38.72 +0.60% 14,473,434
13/08/26 CN¥38.49 +3.72% 21,705,432
12/08/26 CN¥37.11 +0.08% 10,038,222
11/08/26 CN¥37.08 -0.59% 11,306,644

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300723 Stock